|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10,880.00 JPY | +6.77% |
|
+7.88% | +22.62% |
| 03-04 | Irlab Working to Secure Funding for Phase 3 Study of Mesdopetam - fc | FW |
| 02-26 | Irlab Receives $3 Million Milestone Payment Following Dosing in Phase 1b Study | FW |
Main competitors
| 1m. Revenue rev. | 4m. EPS revision | 4m. Revenue rev. | 1y. EPS revision | 1y. Revenue rev. | Visibility | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|
| 12 | ||||||||
| 37 | ||||||||
| 36 | ||||||||
| 30 | ||||||||
| 1 | ||||||||
| 6 | ||||||||
| 12 | ||||||||
| 12 | ||||||||
| 7 | ||||||||
| 16 | ||||||||
| - | - | |||||||
| 12 | ||||||||
| 4 | ||||||||
| 4 | ||||||||
| - | - | - | - | |||||
| 2 | ||||||||
| 3 | ||||||||
| Average | 13 | |||||||
| Weighted average by Cap. | 20 |
- Stock Market
- Equities
- 4578 Stock
- Sector Otsuka Holdings Co., Ltd.
- Sector revisions
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















